Bengaluru: MedGenome, India’s market leader in genetic diagnostics announced that its NGS (Next Generation Sequencing) technology based clinical laboratory in Bangalore has been awarded accreditation from the College of American Pathologists (CAP) based on the results of an on-site inspection.
The CAP Laboratory Accreditation Program is a globally recognized program and is the only one of its kind that utilizes teams of practicing laboratory professionals as inspectors and is designed to go well beyond regulatory compliance.
During the accreditation process, inspectors do a detailed check of the laboratory’s records and quality control procedures. They also assess the laboratory’s staff competency/qualifications, equipment, facilities, safety program, and overall management to ensure it meets CAP’s broad and stringent quality criteria.
This accreditation is awarded to facilities meeting the highest standards of excellence in clinical laboratory practices. With this accreditation, MedGenome’s India laboratory joins the ranks of the most elite laboratories in the world.
“Being awarded the accreditation by CAP is an extremely proud moment for us. It further validates our commitment to provide the highest standards in quality laboratory services” said Dr. V.L Ramprasad, COO MedGenome.
“Having launched India’s first validated Liquid biopsy and the carrier screening tests, we are trying to find answers to some of the most complex diseases. We strive to provide the most accurate results based on thorough and rigorous processes to clinicians across India so that they can produce the best outcomes for patients”.
With this accreditation, MedGenome is the only Indian laboratory to be CAP accredited for Whole genome/exome sequencing, CfDNA (Cell-free DNA) testing for liquid biopsy and NIPT (Non-invasive prenatal screening test) and high-resolution HLA typing.